Welcome to the e-CCO Library Archive!

Filter:
Best abstract: The impact of “Crohn’s Disease-TReatmentwith-EATing“ diet (CD-TREAT diet) and exclusive enteral nutrition on healthy gut bacteria metabolism
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 6: Bugs and drugs in IBD (Keywords: IBD, CD, diet, nutrion, Exclusive Enteral Nutrition, CD- TREAT, diet)
Authors: Vaios Svolos
Best Abstract: The quality of care for inpatients with inflammatory bowel disease in the UK over a six year period
Source: Presentation - ECCO 2013 Vienna Congress - Scientific Session 9: Course and treatment of IBD in the elderly
Authors: Laith Alrubaiy, Ian Arnott, Aimee Protheroe, Michael Roughton, Richard Driscoll, John Williams
Best abstract: The TOPPIC trial: A randomised, double-blind parallel group trial of mercaptopurine vs placebo to prevent recurrence of Crohn’s Disease following surgical resection in 240 patients
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 10: Surgical and endoscopic FAQs in IBD (Keywords: meracaptopurine, CD, postoperative)
Authors: Jack Satsangi
Best abstract: TLR4 signaling activates the WNT pathway in a mouse model of colitis-associated neoplasia
Source: Presentation - ECCO'12 Barcelona Congress
Authors: Rebeca Santaolalla
Best abstract: TNF and MDP induce epithelial-to-mesenchymal transition in human intestinal cells: Implications for the pathogenesis of Crohn's disease-associated fistulae and the use of anti-TNF antibodies
Source: Presentation - ECCO'12 Barcelona Congress
Authors: Michael Scharl
Best abstract: Tralokinumab (CAT-354), an interleukin 13 antibody, in moderate to severe Ulcerative Colitis: A phase 2 randomized placebo-controlled study
Source: Presentation - ECCO 2014 Copenhagen Congress - Scientific session 4: Tomorrow’s therapy: Best abstract: Tralokinumab (CAT-354), an interleukin 13 antibody, in moderate to severe Ulcerative Colitis: A phase 2 randomized placebo-controlled study
Authors: Silvio Danese
Best abstract: Transethnic association study of IBD identifies 14 new disease loci and demonstrates pervasive sharing of genetic risk factors and phenotypic features between Europeans and Non-Europeans
Source: Presentation - ECCO 2014 Copenhagen Congress - Scientific session 7: ECCO Fellowships and Grants: Best abstract: Transethnic association study of IBD identifies 14 new disease loci and demonstrates pervasive sharing of genetic risk factors and phenotypic features between Europeans and Non-Europeans (Keywords: genetic, IBD, CD, UC, Montréal classification)
Authors: Rinse K. Weersma
Best abstract: Transmissive Crohns Disease-like ileitis is caused by functional dysbiosis in the intestinal microbiota independent of inflammation-driven Paneth cell failure
Source: Presentation - ECCO 2015 Barcelona Congress - Scientific Session Scientific session 1: The exposome in the pathogenesis of IBD: Best abstract: Transmissive Crohns Disease-like ileitis is caused by functional dysbiosis in the intestinal microbiota independent of inflammation-driven Paneth cell failure (IBD, CD, microbiotica)
Authors: Schaubeck Monika
Best abstract: TURANDOT: A randomised, multicentre double-blind, placebo-controlled study of the safety and efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in patients with moderate to severe Ulcerative Colitis (UC)
Source: Presentation - ECCO 2015 Barcelona Congress - Scientific session 10: New therapies and strategies
Authors: Séverine Vermeire
Best abstract: UK IBD twin and multiplex registry: Concordance and environmental risk factors of twins with IBD
Source: Presentation - ECCO 2015 Barcelona Congress - Scientific session 1: The exposome in the pathogenesis of IBD
Authors: hannah Gordon
Best abstract: Unchanged surgery and hospitalisation rates in an East-West-European inception cohort despite differences in use of biologicals - 3-year follow-up of the ECCO-EpiCom cohort
Source: Presentation - ECCO 2015 Barcelona Congress - Scientific session 3: Optimal use of resources (Keywords: anti-TNF, AZA, biologic treatment, colectomy, IBD, CD, UC, immunosuppressive agents, infliximab)
Authors: Johan Burisch
Best abstract: Use of anti-TNF-a agents in relation to first-time surgery for Ulcerative Colitis and Crohns Disease during childhood
Source: Presentation - ECCO 2015 Barcelona Congress - Scientific session 6: Anti-TNF: Originators & Biosimilars (Keywords: anti-TNF, CD, UC, pediatric epidemiology)
Authors: Michael Due Larsen
Best abstract: Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with Infliximab for ulcerative colitis
Source: Presentation - ECCO'12 Barcelona Congress
Authors: Martine De Vos
Bile acid therapy in PSC – Relevance and opportunities for novel treatment options
Source: Presentation - ECCO 2014 Copenhagen Congress - PSC Update Forum: Primary Sclerosing Cholangitis (PSC) Update Forum: Bile acid therapy in PSC – Relevance and opportunities for novel treatment options (Keywords: cancer, colorectal cancer surveillance, complications)
Authors: Michael Trauner
Biologic drug levels in practice
Source: Presentation - ECCO 2014 Copenhagen Congress - Scientific session 2: Optimisation of therapy - Biologic drug levels in practice (Keywords: anti-TNF, monitoring, pharmacokinetics)
Authors: Shomron Ben-Horin
Biologicals
Source: Presentation - ECCO 2016 Amsterdam Congress - 5th S-ECCO IBD Masterclass: Session 1: Perianal disease
Authors: William Sandborn
Biologicals
Source: Presentation - ECCO 2016 Amsterdam Congress - 5th S-ECCO IBD Masterclass: Session 3: Crohn’s Disease (Keywords: IBD, CD, UC)
Authors: Ailsa Hart
Biosimilars - Straight ahead or off at a tangent?
Source: Presentation - ECCO 2014 Copenhagen Congress - Scientific session 3: Cost of therapy, burden of care: Biosimilars - Straight ahead or off at a tangent? (Keywords: anti-TNF, IBD, infliximab, pharmacokinetics)
Authors: Pierre Michetti
Building your management algorithm
Source: Presentation - ECCO 2014 Copenhagen Congress - 3rd S-ECCO IBD Masterclass: Session III: Multidisciplinary management - Building your management algorithm (Keywords: abscess, anti-TNF, disease activity, fistula, CD, infliximab, postoperative)
Authors: Léon Maggiori
Can post-operative treatment prevent recurrence?
Source: Presentation - ECCO 2015 Barcelona Congress - Basic ECCO: EduCational COurse for Industry Session: 3 (5-ASA, anti-TNF, AZA, calprotectin, ileocecal resection, postoperative, smoking)
Authors: Domènech Eugeni